首页 > 最新文献

Journal of Clinical Densitometry最新文献

英文 中文
Effects of Abaloparatide or Placebo on Bone Mineral Density in Acetabular Regions Corresponding to DeLee and Charnley Zones in Postmenopausal Women with Osteoporosis 阿巴巴拉肽或安慰剂对绝经后骨质疏松症妇女髋臼区DeLee和Charnley区骨密度的影响
IF 2.5 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-07-01 DOI: 10.1016/j.jocd.2023.101396
Neil P. Sheth MD (Contributing Author) , Mathias P. Bostrom MD (Contributing Author) , Renaud Winzenrieth PhD (Contributing Author Speaker Biography) , Ludovic Humbert PhD (Contributing Author) , Leny Pearman PhD (Contributing Author) , John Caminis MD (Contributing Author) , Yamei Wang PhD (Contributing Author) , John I. Boxberger PhD (Primary Author) , Kelly Krohn MD (Contributing Author)

Purpose/Aims

To evaluate the effects of 6 and 18 mo of abaloparatide (ABL) compared with placebo (PBO) on bone mineral density (BMD) in the acetabular regions of postmenopausal women with osteoporosis (OP).

Rationale/Background

Acetabular bone loss, as may occur in OP, increases risk of acetabular fragility fractures and is associated with significant morbidity. In total hip arthroplasty (THA), low acetabular BMD adversely affects primary stability, osseointegration, and migration of acetabular cups. ABL is an osteoanabolic agent for the treatment of men and postmenopausal women with OP at high risk for fracture that increases BMD of the total hip, femoral neck, trochanter, and lumbar spine. Effects of ABL on acetabular BMD are unknown.

Methods

Hip DXA scans were obtained at baseline, 6, and 18 mo from a random subgroup of postmenopausal women (aged 49–86 y) from the phase 3 ACTIVE trial randomized to either ABL 80 µg/d or PBO (n=250/group).

Anatomical landmarks were identified in each DXA scan to virtually place a hemispherical shell model of an acetabular cup and define regions of interest corresponding to DeLee & Charnley zones 1 (R1), 2 (R2), and 3 (R3). BMD changes compared to baseline were calculated for each zone. Statistical P values were based on a mixed-effect repeated measure model adjusted for BMI, age, and baseline BMD, with covariates including DXA scanner type, treatment group, visit, and treatment/visit interaction. DXA scans were aligned via intensity-based registration onto a reference scan to depict local mean changes in BMD.

Results

BMD in all zones were similar at baseline in the ABL and PBO groups. BMD significantly increased in the ABL group at 6 and 18 mo compared with PBO (all P< 0.0001 vs PBO; Figure), with mean BMD increasing from baseline by 8.38% in R1, 7.25% in R2, and 9.73% in R3 at 18 months. BMD in the PBO group was relatively stable over time.

Implications

Treatment with ABL resulted in rapid and progressive increases in BMD of all 3 acetabular zones. Increasing acetabular BMD has the potential to improve acetabular strength, which may reduce risk of acetabular fragility fractures. With bone health optimization prior to THA, increased acetabular BMD via ABL may provide better primary stability and longevity of acetabular cups in postmenopausal women with OP.

目的/目的与安慰剂(PBO)相比,评估6个月和18个月的阿巴洛肽(ABL)对绝经后骨质疏松症(OP)妇女髋臼区骨密度(BMD)的影响。理由/背景OP中可能发生的髋臼骨丢失会增加髋臼脆性骨折的风险,并与显著的发病率相关。在全髋关节置换术(THA)中,髋臼骨密度低会对髋臼杯的初始稳定性、骨整合和迁移产生不利影响。ABL是一种骨合成代谢剂,用于治疗男性和绝经后女性OP骨折高风险患者,可增加髋关节、股骨颈、大转子和腰椎的BMD。ABL对髋臼骨密度的影响尚不清楚。方法在基线、6个月和18个月时,从3期ACTIVE试验中随机分组的绝经后妇女(年龄49-86岁)中获得髋关节DXA扫描,随机分组为ABL 80µg/d或PBO(n=250/组);Charnley区1(R1)、2(R2)和3(R3)。计算每个区域与基线相比的BMD变化。统计P值基于经BMI、年龄和基线BMD调整的混合效应重复测量模型,协变量包括DXA扫描仪类型、治疗组、就诊和治疗/就诊交互作用。DXA扫描通过基于强度的配准与参考扫描对齐,以描述BMD的局部平均变化。结果ABL和PBO组所有区域的BMD在基线时相似。与PBO相比,ABL组在6个月和18个月时的BMD显著增加(所有P<0.0001 vs PBO;图),18个月后,R1组的平均BMD比基线增加8.38%,R2组增加7.25%,R3组增加9.73%。PBO组的BMD随着时间的推移相对稳定。并发症ABL治疗导致所有3个髋臼区的BMD快速且渐进地增加。增加髋臼骨密度有可能提高髋臼强度,从而降低髋臼脆性骨折的风险。在THA之前进行骨健康优化,通过ABL增加髋臼BMD可以为绝经后OP妇女提供更好的髋臼杯初始稳定性和寿命。
{"title":"Effects of Abaloparatide or Placebo on Bone Mineral Density in Acetabular Regions Corresponding to DeLee and Charnley Zones in Postmenopausal Women with Osteoporosis","authors":"Neil P. Sheth MD (Contributing Author) ,&nbsp;Mathias P. Bostrom MD (Contributing Author) ,&nbsp;Renaud Winzenrieth PhD (Contributing Author Speaker Biography) ,&nbsp;Ludovic Humbert PhD (Contributing Author) ,&nbsp;Leny Pearman PhD (Contributing Author) ,&nbsp;John Caminis MD (Contributing Author) ,&nbsp;Yamei Wang PhD (Contributing Author) ,&nbsp;John I. Boxberger PhD (Primary Author) ,&nbsp;Kelly Krohn MD (Contributing Author)","doi":"10.1016/j.jocd.2023.101396","DOIUrl":"https://doi.org/10.1016/j.jocd.2023.101396","url":null,"abstract":"<div><h3>Purpose/Aims</h3><p>To evaluate the effects of 6 and 18 mo of abaloparatide<span> (ABL) compared with placebo (PBO) on bone mineral density (BMD) in the acetabular<span> regions of postmenopausal women<span> with osteoporosis (OP).</span></span></span></p></div><div><h3>Rationale/Background</h3><p><span>Acetabular bone loss<span><span>, as may occur in OP, increases risk of acetabular fragility fractures and is associated with significant morbidity. In total </span>hip arthroplasty (THA), low acetabular BMD adversely affects primary stability, </span></span>osseointegration<span><span>, and migration of acetabular cups<span>. ABL is an osteoanabolic agent for the treatment of men and postmenopausal women with OP at high risk for fracture that increases BMD of the total hip, </span></span>femoral neck<span>, trochanter, and lumbar spine. Effects of ABL on acetabular BMD are unknown.</span></span></p></div><div><h3>Methods</h3><p>Hip DXA scans were obtained at baseline, 6, and 18 mo from a random subgroup of postmenopausal women (aged 49–86 y) from the phase 3 ACTIVE trial randomized to either ABL 80 µg/d or PBO (n=250/group).</p><p>Anatomical landmarks were identified in each DXA scan to virtually place a hemispherical shell model of an acetabular cup and define regions of interest corresponding to DeLee &amp; Charnley zones 1 (R1), 2 (R2), and 3 (R3). BMD changes compared to baseline were calculated for each zone. Statistical P values were based on a mixed-effect repeated measure model adjusted for BMI, age, and baseline BMD, with covariates including DXA scanner type, treatment group, visit, and treatment/visit interaction. DXA scans were aligned via intensity-based registration onto a reference scan to depict local mean changes in BMD.</p></div><div><h3>Results</h3><p>BMD in all zones were similar at baseline in the ABL and PBO groups. BMD significantly increased in the ABL group at 6 and 18 mo compared with PBO (all P&lt; 0.0001 vs PBO; Figure), with mean BMD increasing from baseline by 8.38% in R1, 7.25% in R2, and 9.73% in R3 at 18 months. BMD in the PBO group was relatively stable over time.</p></div><div><h3>Implications</h3><p>Treatment with ABL resulted in rapid and progressive increases in BMD of all 3 acetabular zones. Increasing acetabular BMD has the potential to improve acetabular strength, which may reduce risk of acetabular fragility fractures. With bone health optimization prior to THA, increased acetabular BMD via ABL may provide better primary stability and longevity of acetabular cups in postmenopausal women with OP.</p></div>","PeriodicalId":50240,"journal":{"name":"Journal of Clinical Densitometry","volume":"26 3","pages":"Article 101396"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49734896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DXA Assessment in Gender Diverse Youth 性别差异青年的DXA评估
IF 2.5 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-07-01 DOI: 10.1016/j.jocd.2023.101411
Sooji Kim BS (Primary Author Research Coordinator) , H. Theodore Harcke MD (Contributing Author Pediatric Radiologist) , Evan Graber DO (Contributing Author) , Heidi H. Kecskemethy MS Ed, RDN, CBDT (Contributing Author)
<div><h3>Purpose/Aims</h3><p>Evaluate DXA in gender diverse youth and examine interpretation of results using male and female reference values.</p></div><div><h3>Rationale/Background</h3><p>Gender affirming care in the US has increased over the past decade. Positions on DXA interpretation in gender diverse (GD) adults exist; guidelines for GD youth are being developed. Standard practice for prepubescent children seeking gender affirming medical care is to start pubertal suppression (PS). Bone mass accrual in the growing skeleton occurs during puberty and the impact of PS on bone mineral density (BMD) is unclear. We examine the practice of reporting results using both male and female norms.</p></div><div><h3>Methods</h3><p>Retrospective review of clinically obtained DXAs and clinical information regarding gender affirming medical care including PS, hormonal replacement therapy (HRT), Tanner score at DXA, fracture history, serum 25(OD)D level, and other bone or nutritional issues in children (< 18 years) seen at our children's hospital prior to 1/11/2023. All had at least one DXA. BMD and z-score for total body less head (TBLH), lumbar spine (LS), and lateral distal femurs (LDF) regions 1 – 3 for both sexes were evaluated. Height-adjusted z-score (HAZ) was used for TBLH and LS. Serial DXA was assessed if available. We evaluated z-score patterns at all body sites comparing natal norms to opposite sex norms.</p></div><div><h3>Results</h3><p>Twenty-four GD children (12 natal female) with a mean age at first DXA of 13.1 years (9.9 to 17) were identified. Twenty-three received PS and 12 received HRT. Half had insufficient/deficient 25(OH)D status, and 33% had history of fracture, consistent with the general pediatric population. All had TBLH and LS; 23 had LDF scans. At first DXA, 13 of 24 (6 natal female) were on PS. Mean age of PS initiation differed by natal sex with girls starting at 12.4 years and boys starting at 14.7 years. Three patients received HRT; all had received PS. When comparing z-scores using both sex normative standards, only the LS showed consistent differences between the sexes: z-scores were lower in natal males using female norms and higher in natal females using male norms. Difference in z-scores varied at all other body sites between the sexes with no trend.</p></div><div><h3>Implications</h3><p>ISCD adult positions for transgender patients advises use of assigned gender reference values for calculation of z-scores. Utilizing this adult position creates problems for interpretation of DXA in children because z- scores are used in pediatrics and bone mass accrual and growth vary by sex and age. PS decreases growth trajectory and BMD further complicating interpretation of results and use of pediatric reference values.</p><p>Analyzing BMD results using both sex norms, using recommended size adjustments to BMD in pediatrics, and providing this information to the treating clinician for consideration of clinical context provides the
目的评估不同性别青年的DXA,并使用男性和女性参考值检查结果的解释。基本原理/背景在过去十年中,美国的性别确认护理有所增加。性别差异(GD)成人的DXA解释存在不同的观点;目前正在为广东青年制定指导方针。寻求性别确认医疗护理的青春期前儿童的标准做法是开始青春期抑制(PS)。骨骼生长过程中的骨量积累发生在青春期,而PS对骨密度(BMD)的影响尚不清楚。我们用男性和女性的标准来检验报告结果的实践。方法回顾性分析儿童临床获得的DXA和有关性别肯定医疗护理的临床信息,包括PS、激素替代疗法(HRT)、DXA Tanner评分、骨折史、血清25(OD)D水平和其他骨骼或营养问题(<18岁)于2023年11月1日前在本儿童医院就诊。所有患者都至少有一个DXA。对男女的骨密度和1 - 3的总体无头(TBLH)、腰椎(LS)和外侧股骨远端(LDF)区域的z-score进行评估。TBLH和LS采用高度调整z评分(HAZ)。如果可用,对串行DXA进行评估。我们评估了所有身体部位的z-score模式,将出生规范与异性规范进行比较。结果共发现GD患儿24例,其中女性12例,平均首次DXA年龄13.1岁(9.9 ~ 17岁)。23人接受PS治疗,12人接受HRT治疗。半数儿童25(OH)D不足/缺乏,33%有骨折史,与一般儿童人群一致。所有患者均有TBLH和LS;23例进行了LDF扫描。在最初的DXA中,24人中有13人(6名出生女性)接受了PS。PS开始的平均年龄因性别而异,女孩开始12.4岁,男孩开始14.7岁。3例患者接受HRT治疗;当使用两种性别规范标准比较z分数时,只有LS显示出性别之间的一致差异:使用女性规范的出生男性的z分数较低,使用男性规范的出生女性的z分数较高。其他身体部位的z分数差异在两性之间没有变化趋势。iscd对跨性别患者的成人位置建议使用指定的性别参考值来计算z分数。使用成人体位会给儿童DXA的解释带来问题,因为z-评分用于儿科,骨量的累积和生长因性别和年龄而异。PS降低生长轨迹和骨密度,进一步使结果的解释和儿童参考值的使用复杂化。使用两性标准分析骨密度结果,使用儿科骨密度的推荐大小调整,并将这些信息提供给治疗临床医生,以考虑临床情况,从而提供最完整的图像。为GD青年编写包含双重规范性结果的标准化DXA报告将有助于报告工作。对于系列测量,标准化报告应强调BMD的系列变化,而不是z分数。
{"title":"DXA Assessment in Gender Diverse Youth","authors":"Sooji Kim BS (Primary Author Research Coordinator) ,&nbsp;H. Theodore Harcke MD (Contributing Author Pediatric Radiologist) ,&nbsp;Evan Graber DO (Contributing Author) ,&nbsp;Heidi H. Kecskemethy MS Ed, RDN, CBDT (Contributing Author)","doi":"10.1016/j.jocd.2023.101411","DOIUrl":"10.1016/j.jocd.2023.101411","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Purpose/Aims&lt;/h3&gt;&lt;p&gt;Evaluate DXA in gender diverse youth and examine interpretation of results using male and female reference values.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Rationale/Background&lt;/h3&gt;&lt;p&gt;Gender affirming care in the US has increased over the past decade. Positions on DXA interpretation in gender diverse (GD) adults exist; guidelines for GD youth are being developed. Standard practice for prepubescent children seeking gender affirming medical care is to start pubertal suppression (PS). Bone mass accrual in the growing skeleton occurs during puberty and the impact of PS on bone mineral density (BMD) is unclear. We examine the practice of reporting results using both male and female norms.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;p&gt;Retrospective review of clinically obtained DXAs and clinical information regarding gender affirming medical care including PS, hormonal replacement therapy (HRT), Tanner score at DXA, fracture history, serum 25(OD)D level, and other bone or nutritional issues in children (&lt; 18 years) seen at our children's hospital prior to 1/11/2023. All had at least one DXA. BMD and z-score for total body less head (TBLH), lumbar spine (LS), and lateral distal femurs (LDF) regions 1 – 3 for both sexes were evaluated. Height-adjusted z-score (HAZ) was used for TBLH and LS. Serial DXA was assessed if available. We evaluated z-score patterns at all body sites comparing natal norms to opposite sex norms.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;p&gt;Twenty-four GD children (12 natal female) with a mean age at first DXA of 13.1 years (9.9 to 17) were identified. Twenty-three received PS and 12 received HRT. Half had insufficient/deficient 25(OH)D status, and 33% had history of fracture, consistent with the general pediatric population. All had TBLH and LS; 23 had LDF scans. At first DXA, 13 of 24 (6 natal female) were on PS. Mean age of PS initiation differed by natal sex with girls starting at 12.4 years and boys starting at 14.7 years. Three patients received HRT; all had received PS. When comparing z-scores using both sex normative standards, only the LS showed consistent differences between the sexes: z-scores were lower in natal males using female norms and higher in natal females using male norms. Difference in z-scores varied at all other body sites between the sexes with no trend.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Implications&lt;/h3&gt;&lt;p&gt;ISCD adult positions for transgender patients advises use of assigned gender reference values for calculation of z-scores. Utilizing this adult position creates problems for interpretation of DXA in children because z- scores are used in pediatrics and bone mass accrual and growth vary by sex and age. PS decreases growth trajectory and BMD further complicating interpretation of results and use of pediatric reference values.&lt;/p&gt;&lt;p&gt;Analyzing BMD results using both sex norms, using recommended size adjustments to BMD in pediatrics, and providing this information to the treating clinician for consideration of clinical context provides the ","PeriodicalId":50240,"journal":{"name":"Journal of Clinical Densitometry","volume":"26 3","pages":"Article 101411"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47349992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bone Mineral Density and Dickkopf-1 in Adolescents with Non-Deletional Hemoglobin H Disease 非缺失性血红蛋白H病青少年的骨矿物质密度和Dickkopf-1
IF 2.5 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-07-01 DOI: 10.1016/j.jocd.2023.101379
Pattara Wiromrat , Aree Rattanathongkom , Napat Laoaroon , Kunanya Suwannaying , Patcharee Komwilaisak , Ouyporn Panamonta , Nantaporn Wongsurawat , Nat Nasomyont

Background: Low bone mineral density (BMD) is prevalent in individuals with β-thalassemia and is associated with increased circulating dickkopf-1 concentration. These data are limited in α-thalassemia. Therefore, we aimed to determine the prevalence of low BMD and the association between BMD and serum dickkopf-1 in adolescents with non-deletional hemoglobin H disease, a form of α-thalassemia whose severity is comparable to β-thalassemia intermedia. Methodology: The lumbar spine and total body BMD were measured and converted into height-adjusted z-scores. Low BMD was defined as BMD z-score ≤ -2. Participant blood was drawn for measurement of dickkopf-1 and bone turnover marker concentrations. Results: Thirty-seven participants with non-deletional hemoglobin H disease (59% female, mean age 14.6 ± 3.2 years, 86% Tanner stage ≥2, 95% regularly transfused, 16% taking prednisolone) were included. Over one year prior to the study, mean average pretransfusion hemoglobin, ferritin and 25-hydroxyvitamin D concentrations were 8.8 ± 1.0 g/dL, and 958 ± 513 and 26 ± 6 ng/mL, respectively. When participants taking prednisolone were excluded, the prevalence of low BMD at the lumbar spine and total body was 42% and 17%, respectively. BMD at both sites was correlated positively with body mass index z-score, and negatively with dickkopf-1 (all p-values <0.05). There were no correlations among dickkopf-1, 25-hydroxyvitamin D, osteocalcin and C-telopeptide of type-I collagen. Multiple regression analysis showed dickkopf-1 inversely associated with total body BMD z-score adjusting for sex, bone age, body mass index, pre-transfusion hemoglobin, 25-hydroxyvitamin D, history of delayed puberty, type of iron chelator and prednisolone use (p-value = 0.009). Conclusions: We demonstrated a high prevalence of low BMD in adolescents with non-deletional hemoglobin H disease. Moreover, dickkopf-1 inversely associated with total body BMD suggesting it may serve as a bone biomarker in this patient population.

背景:低骨密度(BMD)在β地中海贫血患者中普遍存在,并与循环dickkopf-1浓度增加有关。这些数据在α地中海贫血中是有限的。因此,我们旨在确定患有非缺失血红蛋白H疾病的青少年低BMD的患病率以及BMD与血清dickkopf-1之间的关系,非缺失血红蛋白H疾病是一种严重程度与中间型β地中海贫血相当的α-地中海贫血。方法:测量腰椎和全身骨密度,并将其转换为身高调整后的z评分。低BMD定义为BMD z评分≤-2。抽取参与者的血液以测量dickkopf-1和骨转换标志物的浓度。结果:37名患有非缺失性血红蛋白H疾病的参与者(59%为女性,平均年龄14.6±3.2岁,86%的Tanner分期≥2,95%定期输血,16%服用泼尼松)被纳入研究。在研究前一年,平均转化前血红蛋白、铁蛋白和25-羟基维生素D浓度分别为8.8±1.0 g/dL、958±513和26±6 ng/mL。当排除服用泼尼松的参与者时,腰椎和全身骨密度低的患病率分别为42%和17%。两个部位的BMD与体重指数z评分呈正相关,与dickkopf-1呈负相关(p值均<0.05)。Dickkopv-1、25-羟基维生素D、骨钙素和I型胶原C-末端肽之间没有相关性。多元回归分析显示,dickkopf-1与经性别、骨龄、体重指数、输血前血红蛋白、25-羟基维生素D、青春期延迟史、铁螯合剂类型和泼尼松龙使用调整后的全身BMD z评分呈负相关(p值 = 0.009)。结论:我们证明在患有非缺失血红蛋白H疾病的青少年中,低BMD的患病率很高。此外,dickkopf-1与全身BMD呈负相关,这表明它可能是该患者群体的骨生物标志物。
{"title":"Bone Mineral Density and Dickkopf-1 in Adolescents with Non-Deletional Hemoglobin H Disease","authors":"Pattara Wiromrat ,&nbsp;Aree Rattanathongkom ,&nbsp;Napat Laoaroon ,&nbsp;Kunanya Suwannaying ,&nbsp;Patcharee Komwilaisak ,&nbsp;Ouyporn Panamonta ,&nbsp;Nantaporn Wongsurawat ,&nbsp;Nat Nasomyont","doi":"10.1016/j.jocd.2023.101379","DOIUrl":"10.1016/j.jocd.2023.101379","url":null,"abstract":"<div><p><em>Background:</em><span> Low bone mineral density (BMD) is prevalent in individuals with β-thalassemia and is associated with increased circulating dickkopf-1 concentration. These data are limited in α-thalassemia. Therefore, we aimed to determine the prevalence of low BMD and the association between BMD and serum dickkopf-1 in adolescents with non-deletional hemoglobin H disease, a form of α-thalassemia whose severity is comparable to β-thalassemia intermedia. </span><em>Methodology:</em><span><span> The lumbar spine and total body BMD were measured and converted into height-adjusted z-scores. Low BMD was defined as BMD z-score ≤ -2. Participant blood was drawn for measurement of dickkopf-1 and </span>bone turnover marker concentrations. </span><em>Results:</em><span><span><span> Thirty-seven participants with non-deletional hemoglobin H disease (59% female, mean age 14.6 ± 3.2 years, 86% Tanner stage ≥2, 95% regularly transfused, 16% taking prednisolone) were included. Over one year prior to the study, mean average pretransfusion hemoglobin, ferritin<span> and 25-hydroxyvitamin D concentrations were 8.8 ± 1.0 g/dL, and 958 ± 513 and 26 ± 6 ng/mL, respectively. When participants taking prednisolone were excluded, the prevalence of low BMD at the lumbar spine and total body was 42% and 17%, respectively. BMD at both sites was correlated positively with </span></span>body mass index z-score, and negatively with dickkopf-1 (all p-values &lt;0.05). There were no correlations among dickkopf-1, 25-hydroxyvitamin D, </span>osteocalcin<span><span> and C-telopeptide of type-I collagen. Multiple regression analysis showed dickkopf-1 inversely associated with total body BMD z-score adjusting for sex, bone age, body mass index, pre-transfusion hemoglobin, 25-hydroxyvitamin D, history of delayed puberty, type of </span>iron chelator and prednisolone use (p-value = 0.009). </span></span><em>Conclusions:</em> We demonstrated a high prevalence of low BMD in adolescents with non-deletional hemoglobin H disease. Moreover, dickkopf-1 inversely associated with total body BMD suggesting it may serve as a bone biomarker in this patient population.</p></div>","PeriodicalId":50240,"journal":{"name":"Journal of Clinical Densitometry","volume":"26 3","pages":"Article 101379"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10287357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations of Lean Mass, Muscular Strength, and Physical Function with Trabecular Bone Score in Older Adults 老年人瘦质量、肌肉力量和身体功能与小梁骨评分的关系
IF 2.5 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-07-01 DOI: 10.1016/j.jocd.2023.101370
Margaret P. Seaton , Jeanne F. Nichols , Mitchell J. Rauh , Deborah M. Kado , Julie Loebach Wetherell , Eric J. Lenze , David Wing

Introduction/Background: Trabecular bone score (TBS) is an indirect measurement of bone quality and microarchitecture determined from dual-energy X-ray absorptiometry (DXA) imaging of the lumbar spine. TBS predicts fracture risk independent of bone mass/density, suggesting this assessment of bone quality adds value to the understanding of patients’ bone health. While lean mass and muscular strength have been associated with higher bone density and lower fracture risk among older adults, the literature is limited regarding the relationship of lean mass and strength with TBS. The purpose of this study was to determine associations of DXA-determined total body and trunk lean mass, maximal muscular strength, and gait speed as a measure of physical function, with TBS in 141 older adults (65-84 yr, 72.5 +/- 5.1 yr, 74% women). Methodology: Assessments included lumbar spine (L1-L4) bone density and total body and trunk lean mass by DXA, lower body (leg press) and upper body (seated row) strength by one repetition maximum tests, hand grip strength, and usual gait speed. TBS was derived from the lumbar spine DXA scan. Multivariable linear regression determined the contribution of proposed predictors to TBS. Results: After adjusting for age, sex, and lumbar spine bone density, upper body strength significantly predicted TBS (unadjusted/adjusted R2= 0.16/ 0.11, β coefficient =0.378, p=0.005), while total body lean mass index showed a trend in the expected direction (β coefficient =0.243, p=0.053). Gait speed and grip strength were not associated with TBS (p>0.05). Conclusion: Maximum strength of primarily back muscles measured as the seated row appears important to bone quality as measured by TBS, independent of bone density. Additional research on exercise training targeting back strength is needed to determine its clinical utility in preventing vertebral fractures among older adults.

简介/背景:小梁骨评分(TBS)是通过腰椎双能X射线吸收仪(DXA)成像确定的骨质量和微结构的间接测量。TBS可独立于骨量/密度预测骨折风险,这表明这种骨质量评估有助于了解患者的骨健康状况。虽然瘦体重和肌肉力量与老年人较高的骨密度和较低的骨折风险有关,但关于瘦体重和力量与TBS的关系的文献有限。本研究的目的是在141名老年人(65-84岁,72.5+/-5.1岁,74%为女性)中,确定DXA确定的全身和躯干瘦质量、最大肌肉力量和步态速度(作为身体功能的衡量标准)与TBS的关系。方法:评估包括DXA的腰椎(L1-L4)骨密度、全身和躯干瘦质量、一次重复最大测试的下半身(腿部按压)和上半身(坐排)力量、握力和通常步态速度。TBS来源于腰椎DXA扫描。多变量线性回归确定了所提出的预测因子对TBS的贡献。结果:在校正了年龄、性别和腰椎骨密度后,上身力量显著预测TBS(未校正/校正R2=0.16/0.11,β系数=0.378,p=0.005),而全身瘦质量指数显示出朝着预期方向发展的趋势(β系数=0.243,p=0.053)。步态速度和握力与TBS无关(p>0.05)。需要对针对背部力量的运动训练进行进一步研究,以确定其在预防老年人脊椎骨折方面的临床效用。
{"title":"Associations of Lean Mass, Muscular Strength, and Physical Function with Trabecular Bone Score in Older Adults","authors":"Margaret P. Seaton ,&nbsp;Jeanne F. Nichols ,&nbsp;Mitchell J. Rauh ,&nbsp;Deborah M. Kado ,&nbsp;Julie Loebach Wetherell ,&nbsp;Eric J. Lenze ,&nbsp;David Wing","doi":"10.1016/j.jocd.2023.101370","DOIUrl":"10.1016/j.jocd.2023.101370","url":null,"abstract":"<div><p><em>Introduction/Background:</em><span><span> Trabecular bone score (TBS) is an indirect measurement of bone quality and microarchitecture determined from dual-energy X-ray absorptiometry (DXA) imaging of the </span>lumbar spine. TBS predicts fracture risk independent of bone mass/density, suggesting this assessment of bone quality adds value to the understanding of patients’ bone health. While lean mass and muscular strength have been associated with higher bone density and lower fracture risk among older adults, the literature is limited regarding the relationship of lean mass and strength with TBS. The purpose of this study was to determine associations of DXA-determined total body and trunk lean mass, maximal muscular strength, and gait speed as a measure of physical function, with TBS in 141 older adults (65-84 yr, 72.5 +/- 5.1 yr, 74% women). </span><em>Methodology:</em><span> Assessments included lumbar spine (L1-L4) bone density and total body and trunk lean mass by DXA, lower body (leg press) and upper body (seated row) strength by one repetition maximum tests, hand grip strength, and usual gait speed. TBS was derived from the lumbar spine DXA scan. Multivariable linear regression determined the contribution of proposed predictors to TBS. </span><em>Results:</em> After adjusting for age, sex, and lumbar spine bone density, upper body strength significantly predicted TBS (unadjusted/adjusted <em>R</em><sup>2</sup>= 0.16/ 0.11, β coefficient =0.378, <em>p</em><span>=0.005), while total body lean mass index showed a trend in the expected direction (β coefficient =0.243, </span><em>p</em>=0.053). Gait speed and grip strength were not associated with TBS (<em>p</em>&gt;0.05). <em>Conclusion:</em> Maximum strength of primarily back muscles measured as the seated row appears important to bone quality as measured by TBS, independent of bone density. Additional research on exercise <em>training</em><span> targeting back strength is needed to determine its clinical utility in preventing vertebral fractures among older adults.</span></p></div>","PeriodicalId":50240,"journal":{"name":"Journal of Clinical Densitometry","volume":"26 3","pages":"Article 101370"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9932647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Collaborative Approach to Bone Health 骨骼健康的合作方法
IF 2.5 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-07-01 DOI: 10.1016/j.jocd.2023.101391
SHIBI A. Kunjumon (Primary Author)
<div><h3>Purpose/Aims</h3><p>Background: Osteoporosis is a global problem; people living with osteoporosis have increased dramatically in the last few decades due to the aging population and changes in lifestyle. The project aims to improve post-fracture care and use a preventative service for compromised bone quality patients in the Emergency Room (ER). The QI project aims to increase ER providers' awareness about osteoporosis and to refer appropriately to Bone Health Clinic (BHC) to prevent future fractures.</p></div><div><h3>Rationale/Background</h3><p><span>Methods: Most fractures are first treated in the ER, making ER the gateway for treating fractures. A fragility fracture (FF) </span>care pathway<span> was developed to help providers to identify patients at risk for osteoporosis and guide the providers in placing appropriate referrals to BHC. Educational sessions for providers, FF care pathway posters, and modified EPIC discharge smart phrases for fracture patients that prompted the ER providers to add Bone Health recommendations while discharging the FF patients were developed as part of the framework. The number of new fragility fracture patients, including spine fractures, wrist, humerus, and ankle fractures seen in ER with appropriate BH recommendations, ultimately determined the project's success.</span></p></div><div><h3>Brief Description of the Undertaking/Best Practice</h3><p>The Plan-Do-Study-Act (PDSA) model created a process change and improved patient outcomes. The conceptual framework helped to implement the proposed change, ensured leadership and management support, and established the feedback process to sustain the implemented change. Post-fracture care process improvement enabled ER physicians to recommend patients to BHC to ensure appropriate osteoporosis management, resulting in improved care from 2% to 66% of patients with fragility fractures.</p></div><div><h3>Outcomes achieved/documented</h3><p>The outcome measure of the intervention is the percentage of bone health recommendations made by ER providers for fragility fracture patients. The ICD code with fragility fracture patients analyzed in ER data found that 0% to 25% percent of patients were recommended to the BHC through ER providers after the intervention. The process measures report the validity of the intervention and tracked 30% of ER providers who attended the educational session; 10% to 20% of ER providers adhered to the fragility fracture pathway recommendations. Ten percent of patients accepted the BHC referrals. In contrast, 10% of patients were admitted as in-patients after surgery, and 5% of patients were discharged to skilled nursing facilities or hospice for further care without accepting the bone health referrals. Balancing measures increase patient waiting time for BHC appointments to see the provider, estimated three to four weeks from discharge. The conceptual framework emphasizes sustaining improvements; thus, upon QI completion, weekly reports w
目的/目的背景:骨质疏松症是一个全球性问题;在过去的几十年里,由于人口老龄化和生活方式的改变,骨质疏松症患者急剧增加。该项目旨在改善骨折后护理,并在急诊室(ER)为骨骼质量受损的患者提供预防性服务。QI项目旨在提高急诊医生对骨质疏松症的认识,并适当地转介到骨骼健康诊所(BHC),以预防未来的骨折。理由/背景方法:大多数骨折首先在急诊室治疗,使急诊室成为治疗骨折的门户。脆性骨折(FF)护理路径的开发,以帮助供应商识别患者骨质疏松症的风险,并指导供应商在适当的转诊到BHC。作为框架的一部分,为医疗服务提供者提供教育课程、FF护理路径海报,以及为骨折患者修改的EPIC出院智能短语,这些都促使急诊服务提供者在FF患者出院时增加骨骼健康建议。急诊中出现的新发脆性骨折患者(包括脊柱骨折、手腕骨折、肱骨骨折和踝关节骨折)的数量最终决定了项目的成功。计划-执行-研究-行动(PDSA)模式改变了流程,改善了患者的治疗效果。概念框架有助于实施提议的变革,确保领导和管理的支持,并建立反馈过程以维持实施的变革。骨折后护理流程的改进使急诊医生能够向BHC推荐患者,以确保适当的骨质疏松症治疗,从而使脆性骨折患者的护理从2%提高到66%。达到/记录的结果干预措施的结果测量是急诊医生为脆性骨折患者提出的骨骼健康建议的百分比。急诊数据中分析的脆性骨折患者的ICD代码发现,在干预后,0%至25%的患者通过急诊提供者推荐给BHC。过程测量报告了干预的有效性,并跟踪了参加教育会议的30%的急诊室提供者;10% - 20%的急诊医生遵循脆性骨折路径的建议。10%的病人接受了BHC的转诊。相比之下,10%的患者在手术后作为住院患者入院,5%的患者出院到专业护理机构或临终关怀医院接受进一步护理,而没有接受骨骼健康转诊。平衡措施增加了病人等待BHC预约看提供者的时间,估计从出院后三到四周。概念框架强调持续改进;因此,在QI完成后,每周报告将转为每月审查,并将在季度多学科会议上对合规性和财务报告进行评估。这个项目的必要性来自于我的临床经验,我看到一些患者由于未能识别出他们是继发性骨折的高风险患者,也没有采取适当的预防措施,而经常发生骨折。该项目确定了与骨质疏松相关的FF患者的临床问题,并加强了循证实践(EBP),以缩小治疗差距干预措施。该项目提供了一个机会,通过与供应商的合作和协调,通过识别高危患者来减少未来的骨折,促进骨折后护理项目的积极变化。
{"title":"A Collaborative Approach to Bone Health","authors":"SHIBI A. Kunjumon (Primary Author)","doi":"10.1016/j.jocd.2023.101391","DOIUrl":"10.1016/j.jocd.2023.101391","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Purpose/Aims&lt;/h3&gt;&lt;p&gt;Background: Osteoporosis is a global problem; people living with osteoporosis have increased dramatically in the last few decades due to the aging population and changes in lifestyle. The project aims to improve post-fracture care and use a preventative service for compromised bone quality patients in the Emergency Room (ER). The QI project aims to increase ER providers' awareness about osteoporosis and to refer appropriately to Bone Health Clinic (BHC) to prevent future fractures.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Rationale/Background&lt;/h3&gt;&lt;p&gt;&lt;span&gt;Methods: Most fractures are first treated in the ER, making ER the gateway for treating fractures. A fragility fracture (FF) &lt;/span&gt;care pathway&lt;span&gt; was developed to help providers to identify patients at risk for osteoporosis and guide the providers in placing appropriate referrals to BHC. Educational sessions for providers, FF care pathway posters, and modified EPIC discharge smart phrases for fracture patients that prompted the ER providers to add Bone Health recommendations while discharging the FF patients were developed as part of the framework. The number of new fragility fracture patients, including spine fractures, wrist, humerus, and ankle fractures seen in ER with appropriate BH recommendations, ultimately determined the project's success.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Brief Description of the Undertaking/Best Practice&lt;/h3&gt;&lt;p&gt;The Plan-Do-Study-Act (PDSA) model created a process change and improved patient outcomes. The conceptual framework helped to implement the proposed change, ensured leadership and management support, and established the feedback process to sustain the implemented change. Post-fracture care process improvement enabled ER physicians to recommend patients to BHC to ensure appropriate osteoporosis management, resulting in improved care from 2% to 66% of patients with fragility fractures.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Outcomes achieved/documented&lt;/h3&gt;&lt;p&gt;The outcome measure of the intervention is the percentage of bone health recommendations made by ER providers for fragility fracture patients. The ICD code with fragility fracture patients analyzed in ER data found that 0% to 25% percent of patients were recommended to the BHC through ER providers after the intervention. The process measures report the validity of the intervention and tracked 30% of ER providers who attended the educational session; 10% to 20% of ER providers adhered to the fragility fracture pathway recommendations. Ten percent of patients accepted the BHC referrals. In contrast, 10% of patients were admitted as in-patients after surgery, and 5% of patients were discharged to skilled nursing facilities or hospice for further care without accepting the bone health referrals. Balancing measures increase patient waiting time for BHC appointments to see the provider, estimated three to four weeks from discharge. The conceptual framework emphasizes sustaining improvements; thus, upon QI completion, weekly reports w","PeriodicalId":50240,"journal":{"name":"Journal of Clinical Densitometry","volume":"26 3","pages":"Article 101391"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43490165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fragility Fracture Network Malaysia (FFNM) Fracture Liaison Service (FLS) Framework FFNM promotes multidisciplinary approach on fragility fracture care. It aims to create a national network of fragility fracture care. FLS is a relatively new approach fragility fracture care in Malaysia. The Framework functions as a systematic guide to achieve these goals. It provides a common platform for all FLS to work together for a successful outcome and sustainability. Minimum Common Dataset (MCD) has been incorporated into the Framework to have standardized data collection. 脆弱性骨折网络马来西亚(FFNM)骨折联络服务(FLS)框架FFNM促进脆弱性骨折护理的多学科方法。它的目标是建立一个全国性的脆性骨折护理网络。FLS在马来西亚是一种相对较新的脆弱性骨折护理方法。该框架作为实现这些目标的系统指南。它为所有FLS提供了一个共同的平台,以共同努力取得成功和可持续发展。最小公共数据集(MCD)已被纳入该框架,以实现标准化的数据收集。
IF 2.5 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-07-01 DOI: 10.1016/j.jocd.2023.101388
JOON KIONG LEE (Primary Author Speaker Biography) , ELIZABETH GAR MIT CHONG (Contributing Author) , JULIA PATRICK ENGKASAN (Contributing Author) , SITI NURBAYA MOHD NAWI (Contributing Author Consultant Geriatrician) , TERENCE ONG (Contributing Author Consultant Geriatrician) , SANKARA KUMAR CHANDRASEKARAN (Contributing Author) , PAUL JAMES MITCHELL (Contributing Author Consultant Orthopedic Surgeon)

Purpose/Aims

FFNM aims to create a national network of fragility fracture care, with the participation of various clinical specialists, allied health and primary care physician from different states throughout Malaysia. Fracture Liaison Service (FLS) is a relatively new approach and platform promoting fragility fracture care in Malaysia.

Rationale/Background

The Fragility Fracture Network of Malaysia (FFNM) which was formed in 2018, is a national organization aiming to promote multidisciplinary input on the three pillars of fragility fracture care which include post- fracture acute care, post-fracture rehabilitation and secondary fracture prevention.

Brief Description of the Undertaking/Best Practice

FFNM FLS Framework functions as a systematic guide to achieve these goals. It provides a common platform for all FLS to work together for a successful outcome and sustainability. It highlights the rationale and importance of an FLS to all who are interested in the initiation of FLS in their practice. The Framework provides a guide on how to initiate a new FLS or improve an existing FLS in their practice. It also illustrates the different models of care available and the success stories of some regional and global FLS models as a guide. A Minimum Common Dataset (MCD) has been designed and added into the Framework in order to assist all the FLS in Malaysia to have standardized data captured for comparison and assessment of Key Performance Indicators (KPI) that is crucial to improve services and optimize the benefit for patients.

Outcomes achieved/documented

In 2017, there was only one FLS service available (Beacon Hospital). In 2022, four years FFNM was formed, there are twenty FLS services available throughout the country, with eight being mapped on the International Osteoporosis Foundation (IOF) Capture the Fracture World Map. By establishing a framework, guidelines and standard of best practice in managing various fragility fractures, our patients presenting with fragility fractures will be allowed to return to their best functional status possible.

Conclusions

FFNM FLS Framework has been recognized and accepted as the guide for all existing FLS services to improve their outcome and also for all potential FLS services to initiate their FLS services in their hospitals.

目的/目的FNM旨在建立一个全国脆性骨折护理网络,来自马来西亚不同州的各种临床专家、专职卫生和初级保健医生参与其中。骨折联络服务(FLS)是马来西亚促进脆性骨折护理的一种相对较新的方法和平台。国家/背景马来西亚脆性骨折网络(FFNM)成立于2018年,是一个国家组织,旨在促进对脆性骨折护理三大支柱的多学科投入,骨折后康复和继发性骨折预防。承诺/最佳实践简述FFNM FLS框架是实现这些目标的系统指南。它为所有FLS提供了一个共同的平台,让他们共同努力,取得成功并实现可持续发展。它强调了FLS对所有有兴趣在其实践中启动FLS的人的基本原理和重要性。该框架提供了如何在实践中启动新的FLS或改进现有FLS的指南。它还说明了可用的不同护理模式以及一些区域和全球FLS模式的成功案例,作为指南。设计了一个最小通用数据集(MCD)并将其添加到框架中,以帮助马来西亚的所有FLS获取标准化数据,用于比较和评估关键绩效指标(KPI),这对改善服务和优化患者福利至关重要。取得的成果/记录2017年,只有一项FLS服务可用(Beacon医院)。2022年,在FFNM成立四年的时间里,全国有20个FLS服务,其中8个服务被绘制在国际骨质疏松基金会(IOF)的骨折世界地图上。通过建立管理各种脆性骨折的最佳实践框架、指南和标准,我们的脆性骨折患者将能够恢复到最佳功能状态。结论sFFNM-FLS框架已被认可并接受为所有现有FLS服务的指南,以改善其结果,也为所有潜在的FLS服务在其医院启动其FLS服务提供指南。
{"title":"Fragility Fracture Network Malaysia (FFNM) Fracture Liaison Service (FLS) Framework FFNM promotes multidisciplinary approach on fragility fracture care. It aims to create a national network of fragility fracture care. FLS is a relatively new approach fragility fracture care in Malaysia. The Framework functions as a systematic guide to achieve these goals. It provides a common platform for all FLS to work together for a successful outcome and sustainability. Minimum Common Dataset (MCD) has been incorporated into the Framework to have standardized data collection.","authors":"JOON KIONG LEE (Primary Author Speaker Biography) ,&nbsp;ELIZABETH GAR MIT CHONG (Contributing Author) ,&nbsp;JULIA PATRICK ENGKASAN (Contributing Author) ,&nbsp;SITI NURBAYA MOHD NAWI (Contributing Author Consultant Geriatrician) ,&nbsp;TERENCE ONG (Contributing Author Consultant Geriatrician) ,&nbsp;SANKARA KUMAR CHANDRASEKARAN (Contributing Author) ,&nbsp;PAUL JAMES MITCHELL (Contributing Author Consultant Orthopedic Surgeon)","doi":"10.1016/j.jocd.2023.101388","DOIUrl":"https://doi.org/10.1016/j.jocd.2023.101388","url":null,"abstract":"<div><h3>Purpose/Aims</h3><p>FFNM aims to create a national network of fragility fracture care, with the participation of various clinical specialists, allied health and primary care physician from different states throughout Malaysia. Fracture Liaison Service (FLS) is a relatively new approach and platform promoting fragility fracture care in Malaysia.</p></div><div><h3>Rationale/Background</h3><p>The Fragility Fracture Network of Malaysia (FFNM) which was formed in 2018, is a national organization aiming to promote multidisciplinary input on the three pillars of fragility fracture care which include post- fracture acute care, post-fracture rehabilitation and secondary fracture prevention.</p></div><div><h3>Brief Description of the Undertaking/Best Practice</h3><p>FFNM FLS Framework functions as a systematic guide to achieve these goals. It provides a common platform for all FLS to work together for a successful outcome and sustainability. It highlights the rationale and importance of an FLS to all who are interested in the initiation of FLS in their practice. The Framework provides a guide on how to initiate a new FLS or improve an existing FLS in their practice. It also illustrates the different models of care available and the success stories of some regional and global FLS models as a guide. A Minimum Common Dataset (MCD) has been designed and added into the Framework in order to assist all the FLS in Malaysia to have standardized data captured for comparison and assessment of Key Performance Indicators (KPI) that is crucial to improve services and optimize the benefit for patients.</p></div><div><h3>Outcomes achieved/documented</h3><p>In 2017, there was only one FLS service available (Beacon Hospital). In 2022, four years FFNM was formed, there are twenty FLS services available throughout the country, with eight being mapped on the International Osteoporosis Foundation (IOF) Capture the Fracture World Map. By establishing a framework, guidelines and standard of best practice in managing various fragility fractures, our patients presenting with fragility fractures will be allowed to return to their best functional status possible.</p></div><div><h3>Conclusions</h3><p>FFNM FLS Framework has been recognized and accepted as the guide for all existing FLS services to improve their outcome and also for all potential FLS services to initiate their FLS services in their hospitals.</p></div>","PeriodicalId":50240,"journal":{"name":"Journal of Clinical Densitometry","volume":"26 3","pages":"Article 101388"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49737309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medical imaging measurement of visceral adipose tissue thresholds associated with increased risk of cardiometabolic disease 与心脏代谢疾病风险增加相关的内脏脂肪组织阈值的医学成像测量
IF 2.5 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-07-01 DOI: 10.1016/j.jocd.2023.101387
J. Bennett, M. Wong, Carla Prado, S. Heymsfield, J. Shepherd
{"title":"Medical imaging measurement of visceral adipose tissue thresholds associated with increased risk of cardiometabolic disease","authors":"J. Bennett, M. Wong, Carla Prado, S. Heymsfield, J. Shepherd","doi":"10.1016/j.jocd.2023.101387","DOIUrl":"https://doi.org/10.1016/j.jocd.2023.101387","url":null,"abstract":"","PeriodicalId":50240,"journal":{"name":"Journal of Clinical Densitometry","volume":"1 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54678736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bibliometric Analysis of Geriatric Sarcopenia Therapies: Highlighting Publication Trends and Leading-Edge Research Directions 老年Sarcopenia疗法的文献计量分析:突出出版趋势和前沿研究方向
IF 2.5 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-07-01 DOI: 10.1016/j.jocd.2023.101381
Kaixi Ding , Wei Jiang , Dingqi Li, Chaofang Lei, Chunping Xiong, Ming Lei

The bibliometric analysis assesses the productivity of scholarship in a given field and provides information on the frontiers of relevant developments. However, no bibliometric analysis study has quantitatively analyzed publications in geriatric sarcopenia therapies. This study investigates the scholarly productivity and frontiers of publications in geriatric sarcopenia therapies. The bibliometric data came from English-language Web of Science Core Collection articles published between 1995 and October 19, 2022. Three software programs, R version 3.5.6, VOSviewer, and CiteSpace, were applied for this bibliometric analysis. In twenty-eight years, the annual publications in geriatric sarcopenia therapies have increased yearly, with an annual growth rate of 21.23 %. A total of 1379 publications have been published. The United States was the country with the highest number of publication signatures (n=1,537) (including joint publication releases), followed by Japan (n=1099). Journal of Cachexia, Sarcopenia, and Muscle contributed the best journal publications (n=80). The newest hot subjects in the study about geriatric sarcopenia therapy include malnutrition, obesity, insulin resistance, and cancer. This bibliometric study presents a comprehensive overview of the current and future research directions in geriatric sarcopenia therapies over the past 28 years. Overall, this study has complemented the gaps in bibliometric analysis in geriatric sarcopenia therapies. This paper will provide a valuable reference for future research in geriatric sarcopenia therapies.

文献计量学分析评估了特定领域的学术生产力,并提供了有关相关发展前沿的信息。然而,没有文献计量分析研究对老年少肌症治疗的出版物进行定量分析。本研究调查了老年少肌症治疗的学术生产力和出版物的前沿。文献计量数据来自1995年至2022年10月19日期间发表的英文科学网核心收藏文章。本次文献计量分析采用了R 3.5.6版、VOSviewer和CiteSpace三个软件程序。二十八年来,老年少肌症治疗的年度出版物每年都在增加,年增长率为21.23%。总共出版了1379份出版物。美国是出版物签名人数最多的国家(1537人)(包括联合出版物),其次是日本(1099人)。《恶病质杂志》、《肌肉学杂志》贡献了最好的期刊出版物(n=80)。老年少肌症治疗的最新研究热点包括营养不良、肥胖、胰岛素抵抗和癌症。这项文献计量学研究全面概述了过去28年来老年少肌症治疗的当前和未来研究方向。总的来说,这项研究补充了老年少肌症治疗中文献计量分析的空白。本文将为今后老年少肌症治疗的研究提供有价值的参考。
{"title":"Bibliometric Analysis of Geriatric Sarcopenia Therapies: Highlighting Publication Trends and Leading-Edge Research Directions","authors":"Kaixi Ding ,&nbsp;Wei Jiang ,&nbsp;Dingqi Li,&nbsp;Chaofang Lei,&nbsp;Chunping Xiong,&nbsp;Ming Lei","doi":"10.1016/j.jocd.2023.101381","DOIUrl":"10.1016/j.jocd.2023.101381","url":null,"abstract":"<div><p><span>The bibliometric analysis assesses the productivity of scholarship in a given field and provides information on the frontiers of relevant developments. However, no bibliometric analysis study has quantitatively analyzed publications in geriatric </span>sarcopenia<span><span> therapies. This study investigates the scholarly productivity and frontiers of publications in geriatric sarcopenia therapies. The bibliometric data came from English-language Web of Science Core Collection articles published between 1995 and October 19, 2022. Three software programs, R version 3.5.6, VOSviewer, and CiteSpace, were applied for this bibliometric analysis. In twenty-eight years, the annual publications in geriatric sarcopenia therapies have increased yearly, with an annual growth rate of 21.23 %. A total of 1379 publications have been published. The United States was the country with the highest number of publication signatures (n=1,537) (including joint publication releases), followed by Japan (n=1099). Journal of </span>Cachexia, Sarcopenia, and Muscle contributed the best journal publications (n=80). The newest hot subjects in the study about geriatric sarcopenia therapy include malnutrition, obesity, insulin resistance, and cancer. This bibliometric study presents a comprehensive overview of the current and future research directions in geriatric sarcopenia therapies over the past 28 years. Overall, this study has complemented the gaps in bibliometric analysis in geriatric sarcopenia therapies. This paper will provide a valuable reference for future research in geriatric sarcopenia therapies.</span></p></div>","PeriodicalId":50240,"journal":{"name":"Journal of Clinical Densitometry","volume":"26 3","pages":"Article 101381"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9984583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Effects of a 1-Year Recreational Kung Fu Protocol on Bone Health Parameters in a Group of Healthy Inactive Young Men 1年娱乐性功夫方案对一组健康无运动年轻男性骨骼健康参数的影响
IF 2.5 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-07-01 DOI: 10.1016/j.jocd.2023.101418
Nour Khalil , Antonio Pinti , Rawad El Hage

The main aim of the current study was to explore the effects of a 1-year recreational Kung Fu protocol on bone health parameters (bone mineral content (BMC), bone mineral density (BMD), femoral neck geometry and composite indices of femoral neck strength) in a group of healthy inactive young men. 54 young inactive men voluntarily participated in this study, but only 51 of them completed it. The participants were assigned to 2 different groups: control group (n=31) and Kung Fu group (n=20). The Kung Fu group performed two sessions of recreational Kung Fu per week; the duration of each session was 45 minutes. The current study has demonstrated that whole body (WB) BMC, ultra-distal (UD) radius BMD, 1/3 radius BMD, total radius BMD, total forearm BMD, maximal strength, maximum oxygen consumption and jumping performance increased in the Kung Fu group but not in the control group. The percentages of variations in WB BMC, forearm BMD and physical performance parameters were significantly different between the two groups. In conclusion, this study suggests that recreational Kung Fu is an effective method to improve WB BMC, forearm BMD and physical performance parameters in young inactive men.

本研究的主要目的是探讨一年娱乐功夫方案对一组健康、不活跃的年轻男性骨骼健康参数(骨矿物质含量(BMC)、骨矿物质密度(BMD)、股骨颈几何形状和股骨颈强度综合指数)的影响。54名不活跃的年轻男性自愿参与了这项研究,但其中只有51人完成了这项工作。参与者被分为两组:对照组(n=31)和功夫组(n=20)。功夫组每周表演两次娱乐功夫;每次会话的持续时间为45分钟。目前的研究表明,功夫组的全身(WB)BMC、桡骨超远端(UD)BMD、1/3桡骨BMD、桡骨总BMD、前臂总骨密度、最大力量、最大耗氧量和跳跃性能有所提高,而对照组则没有。WB BMC、前臂BMD和身体性能参数的变化百分比在两组之间有显著差异。总之,本研究表明,娱乐功夫是改善年轻不活跃男性WB BMC、前臂BMD和身体性能参数的有效方法。
{"title":"The Effects of a 1-Year Recreational Kung Fu Protocol on Bone Health Parameters in a Group of Healthy Inactive Young Men","authors":"Nour Khalil ,&nbsp;Antonio Pinti ,&nbsp;Rawad El Hage","doi":"10.1016/j.jocd.2023.101418","DOIUrl":"10.1016/j.jocd.2023.101418","url":null,"abstract":"<div><p>The main aim of the current study was to explore the effects of a 1-year recreational Kung Fu protocol on bone health parameters (bone mineral content (BMC), bone mineral density (BMD), femoral neck geometry and composite indices of femoral neck strength) in a group of healthy inactive young men. 54 young inactive men voluntarily participated in this study, but only 51 of them completed it. The participants were assigned to 2 different groups: control group (n=31) and Kung Fu group (n=20). The Kung Fu group performed two sessions of recreational Kung Fu per week; the duration of each session was 45 minutes. The current study has demonstrated that whole body (WB) BMC, ultra-distal (UD) radius BMD, 1/3 radius BMD, total radius BMD, total forearm BMD, maximal strength, maximum oxygen consumption and jumping performance increased in the Kung Fu group but not in the control group. The percentages of variations in WB BMC, forearm BMD and physical performance parameters were significantly different between the two groups. In conclusion, this study suggests that recreational Kung Fu is an effective method to improve WB BMC, forearm BMD and physical performance parameters in young inactive men.</p></div>","PeriodicalId":50240,"journal":{"name":"Journal of Clinical Densitometry","volume":"26 3","pages":"Article 101418"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10306155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival Analysis of Skeletal Related Events in HR+ Breast Cancer Patients Based on Single NucleotidePolymorphism of ERα Gene 基于ERα基因单核苷酸多态性的HR+乳腺癌症患者骨骼相关事件生存分析
IF 2.5 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-07-01 DOI: 10.1016/j.jocd.2023.101402
Yulian Yin (Primary Author), Yiwei Fan (Contributing Author), Meiling Chu (Contributing Author), Hongfeng Chen (Contributing Author)
<div><h3>Purpose/Aims</h3><p>To investigate the correlation between the occurrence of G and C alleles at rs9340799 and rs2234693 of the ERα gene and the occurrence and development of bone metastasis and skeletal related events (such as bone pain, pathological fracture and osteoporosis) in HR+ breast cancer patients.</p></div><div><h3>Rationale/Background</h3><p>Endocrine therapy is the mainstay of treatment in HR+ breast cancers, accounting for about 70% of all breast cancers. The current literature identifies the most common metastatic site of HR+ breast cancer as the skeletal system (59.2%). A series of skeletal related events, such as bone pain, osteoporosis, hypercalcemia, and pathological fracture, have a significant impact on the life quality of breast cancer patients.However, there has been little progress in the diagnosis and treatment.ERα gene is related to the risk of breast cancer and advanced metastasis. Our previous studies showed that SNPs of the ERα gene indicated that patients with G and C alleles at rs9340799 and rs2234693 had a high incidence of abnormal bone metabolism. The effect of ERα SNPs on susceptibility to abnormal bone metabolism suggests that different gene subtypes lead to abnormal estrogen receptor function and destroy the balance of the microenvironment in bone. It is simply a natural attraction for tumor cells to induce the colonization of circulating tumor cells in bone tissue.</p></div><div><h3>Methods</h3><p>All subjects took AIs and came from Longhua Hospital affiliated with Shanghai University of Traditional Chinese Medicine (2016.1-2017.12). Whole blood samples were collected for ERα gene DNA sequence information. Those who simultaneously contained G and C alleles were defined as group A, and those who did not contain G and C alleles or only contained a single site were defined as group B. Survival status, disease progression, and appearance time were recorded for both groups. Finally, 71 patients were followed up. Kaplan-Meier survival curves were drawn for the results and a single factor COX risk regression analysis was performed.</p></div><div><h3>Results</h3><p>Total follow-up duration was up to 182 months, and median follow-up was 89 months.① The K-M curve with skeletal related events as the primary endpoint was drawn for survival analysis, and the difference was statistically significant by Log-Rank test (P < 0.05). Median survival without skeletal related events in group A was 96.00 ± 12.53 months and 149.00 ± 40.92 months lower than in group B; there was no statistical difference in single factor COX risk assessment (P > 0.05). ② The K-M curve plotted with the occurrence of bone metastasis or disease progression as the primary endpoint showed a statistically significant difference by Log-Rank test (P < 0.05). The mean progression-free survival time in group A was shorter than in group B, 103.73 ± 5.23 months and 153.83 ± 12.65 months, respectively. The single factor COX risk assessment showed
目的探讨ERα基因rs9340799、rs2234693位点G、C等位基因的出现与HR+乳腺癌患者骨转移及骨骼相关事件(如骨痛、病理性骨折、骨质疏松)发生发展的相关性。理论基础/背景:髓质治疗是HR+乳腺癌的主要治疗方法,约占所有乳腺癌的70%。目前的文献表明,HR+乳腺癌最常见的转移部位是骨骼系统(59.2%)。骨痛、骨质疏松、高钙血症、病理性骨折等一系列骨骼相关事件对乳腺癌患者的生活质量有显著影响。然而,在诊断和治疗方面进展甚微。ERα基因与乳腺癌发生风险及晚期转移有关。我们前期的研究表明,ERα基因的snp表明,在rs9340799和rs2234693位点携带G和C等位基因的患者骨代谢异常的发生率较高。ERα snp对骨代谢异常易感性的影响表明,不同基因亚型导致雌激素受体功能异常,破坏骨微环境平衡。肿瘤细胞诱导循环肿瘤细胞在骨组织中定植只是一种自然吸引。方法所有受试者均采用AIs,来自上海中医药大学附属龙华医院(2016.1-2017.12)。采集全血ERα基因DNA序列信息。同时含有G和C等位基因的定义为A组,不含G和C等位基因或仅含有单个位点的定义为b组。记录两组的生存状况、疾病进展和出现时间。最后对71例患者进行随访。绘制Kaplan-Meier生存曲线,并进行单因素COX风险回归分析。结果总随访时间为182个月,中位随访时间为89个月。①绘制以骨骼相关事件为主要终点的K-M曲线进行生存分析,经Log-Rank检验,差异有统计学意义(P <0.05)。A组无骨骼相关事件的中位生存期分别比B组低96.00±12.53个月和149.00±40.92个月;单因素COX风险评估(P >0.05)。②以骨转移发生或疾病进展为主要终点绘制的K-M曲线经Log-Rank检验(P <0.05)。A组患者的平均无进展生存期较B组短,分别为103.73±5.23个月和153.83±12.65个月。单因素COX风险评估差异有统计学意义(P <0.05)。伴有G和C等位基因的HR+乳腺癌患者更易发生骨痛、骨质疏松和骨转移。ERα基因snp可能是HR+患者骨转移进展的独立危险因素。我们建议采用更大样本量的前瞻性研究。
{"title":"Survival Analysis of Skeletal Related Events in HR+ Breast Cancer Patients Based on Single NucleotidePolymorphism of ERα Gene","authors":"Yulian Yin (Primary Author),&nbsp;Yiwei Fan (Contributing Author),&nbsp;Meiling Chu (Contributing Author),&nbsp;Hongfeng Chen (Contributing Author)","doi":"10.1016/j.jocd.2023.101402","DOIUrl":"10.1016/j.jocd.2023.101402","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Purpose/Aims&lt;/h3&gt;&lt;p&gt;To investigate the correlation between the occurrence of G and C alleles at rs9340799 and rs2234693 of the ERα gene and the occurrence and development of bone metastasis and skeletal related events (such as bone pain, pathological fracture and osteoporosis) in HR+ breast cancer patients.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Rationale/Background&lt;/h3&gt;&lt;p&gt;Endocrine therapy is the mainstay of treatment in HR+ breast cancers, accounting for about 70% of all breast cancers. The current literature identifies the most common metastatic site of HR+ breast cancer as the skeletal system (59.2%). A series of skeletal related events, such as bone pain, osteoporosis, hypercalcemia, and pathological fracture, have a significant impact on the life quality of breast cancer patients.However, there has been little progress in the diagnosis and treatment.ERα gene is related to the risk of breast cancer and advanced metastasis. Our previous studies showed that SNPs of the ERα gene indicated that patients with G and C alleles at rs9340799 and rs2234693 had a high incidence of abnormal bone metabolism. The effect of ERα SNPs on susceptibility to abnormal bone metabolism suggests that different gene subtypes lead to abnormal estrogen receptor function and destroy the balance of the microenvironment in bone. It is simply a natural attraction for tumor cells to induce the colonization of circulating tumor cells in bone tissue.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;p&gt;All subjects took AIs and came from Longhua Hospital affiliated with Shanghai University of Traditional Chinese Medicine (2016.1-2017.12). Whole blood samples were collected for ERα gene DNA sequence information. Those who simultaneously contained G and C alleles were defined as group A, and those who did not contain G and C alleles or only contained a single site were defined as group B. Survival status, disease progression, and appearance time were recorded for both groups. Finally, 71 patients were followed up. Kaplan-Meier survival curves were drawn for the results and a single factor COX risk regression analysis was performed.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;p&gt;Total follow-up duration was up to 182 months, and median follow-up was 89 months.① The K-M curve with skeletal related events as the primary endpoint was drawn for survival analysis, and the difference was statistically significant by Log-Rank test (P &lt; 0.05). Median survival without skeletal related events in group A was 96.00 ± 12.53 months and 149.00 ± 40.92 months lower than in group B; there was no statistical difference in single factor COX risk assessment (P &gt; 0.05). ② The K-M curve plotted with the occurrence of bone metastasis or disease progression as the primary endpoint showed a statistically significant difference by Log-Rank test (P &lt; 0.05). The mean progression-free survival time in group A was shorter than in group B, 103.73 ± 5.23 months and 153.83 ± 12.65 months, respectively. The single factor COX risk assessment showed","PeriodicalId":50240,"journal":{"name":"Journal of Clinical Densitometry","volume":"26 3","pages":"Article 101402"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46991305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Densitometry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1